The global electrophysiology device market size was valued at 5.1 billion in 2018. Increasing use of electrophysiological devices in the diagnosis and treatment of cardiovascular diseases such as atrial fibrillation, increasing demand for heart rhythm management devices for continuous monitoring, and increasing use of these devices the hospital environment has a significant impact on rendering the growth engine of the market.
Among millennials, the increasing number of lifestyle-induced heart failure (HF) and heart attack cases such as smoking and excessive alcohol use is a major factor driving the market.
A full report of Electrophysiology Market available at https://www.orionmarketreports.com/electrophysiology-market/10684/
Few of the major competitors currently working in the global electrophysiology devices market are Medtronic; Boston Scientific Corporation; Abbott; Biosense Webster, Inc; Biotronik; General Electric Company; Siemens Healthcare GmbH; MicroPort Scientific Corporation; Koninklijke Philips N.V.; NIHON KOHDEN CORPORATION; CardioFocus; Stereotaxis, Inc.; Molecular Devices, LLC among others.
Global Medical Bed Market Segmentations
By Product
• EP Ablation Catheters
• EP Laboratory Devices
• EP Diagnostic Catheters
• Access Devices
• Others
By Indication
• Atrial Fibrillation (AF)
• Atrial Flutter
• Wolff-Parkinson-White Syndrome (WPW)
• Atrioventricular Nodal Reentry Tachycardia (AVNRT)
• Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
